GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Sexually Transmitted Infections Clinical Trials Group

$210,011
Klausner Jeffrey · Social And Scientific Systems, Inc. · N01 · FY2018 · AI

Salmonella's RpoE-Regulated Starvation-Stress Response

$210,000
University Of South Alabama · R15 · FY2004 · AI

Virulence-conferring siderophore biosynthesis inhibitors

$210,000
Weill Medical College Of Cornell Univ · R21 · FY2005 · AI

CATHELICIDINS--A MOLECULAR BACTERIOLOGIC APPROACH

$210,000
Veterans Medical Research Fdn/San Diego · R21 · FY2001 · AI

CATHELICIDINS--A MOLECULAR BACTERIOLOGIC APPROACH

$210,000
Veterans Medical Research Fdn/San Diego · R21 · FY2000 · AI

Novel antimicrobials targeting type IV pilus and type 2 secretion systems

$209,911
Michael S Donnenberg · University Of Maryland Baltimore · R21 · FY2015 · AI

Adherence mechanisms of Moraxella catarrhalis

$209,785
Eric R Lafontaine · University Of Georgia · R01 · FY2007 · AI

REGULATION OF P AERUGINOSA MOTILITY AND VIRULENCE

$209,677
Wake Forest University Health Sciences · R01 · FY2000 · AI

Nanoscale Encapsulation for Fragment Based Drug Discovery

$209,670
A. Joshua Wand · University Of Pennsylvania · R21 · FY2016 · CA

Ultrasensitive, rapid, cost-effective, user-friendly test for respiratory viruses

$209,600
Sadanand Gite · First Light Diagnostics , Inc. · R43 · FY2008 · AI

Mathematical, Computational, and Predictive Modeling Core

$209,420
Laurent Hã‰bert-Dufresne · University Of Vermont & St Agric College · P20 · FY2025 · GM

The role of alveolar macrophages during tuberculosis: detrimental or beneficial

$209,375
Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · AI

A Novel High-Throughput Exploration of DNA Supercoiling toward the Therapeutic Manipulation of Bacteria

$209,375
Eduardo A. Groisman · Yale University · R21 · FY2024 · AI

Granulysin and the antimicrobial activity of CD8T cells - development of a better model

$209,375
Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2021 · AI

Development of nucleic acid-based vaccines against gonorrhea

$209,375
Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R21 · FY2023 · AI

Site-directed spin labeling of ArnT

$209,288
Candice S Klug · Medical College Of Wisconsin · R01 · FY2008 · AI

A New Multi-Constituent Mode of Action for Goldenseal (Hydrastis canadensis)

$209,250
Nadja B Cech · University Of North Carolina Greensboro · R15 · FY2009 · AT

Recombination-quiescent genes & phylogenic validation of encoded vaccine targets

$209,138
Richard Goldstein · Boston Medical Center · R21 · FY2011 · AI

Dendritic Cell Restriction and Innate Immune Sensing of HIV Infection

$209,138
Dan R Littman · New York University School Of Medicine · R21 · FY2011 · AI

Exploiting new drug targets in extremely resistant M.abscessus by using small molecule Lipid II binders

$209,105
Yutaka Tagaya · University Of Maryland Baltimore · R21 · FY2021 · AI

Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae

$209,102
Robert A. Bonomo · Case Western Reserve University · R21 · FY2015 · AI

Molecular and Structural Bases of Polymyxin Resistance

$209,074
Eduardo A. Groisman · Washington University · R01 · FY2007 · AI

Fusidic acid derivatization to enhance entry into Gram-negative pathogens

$209,030
James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2020 · AI

Interaction of Pseudomonas Aeroginosa with the Mucosal Barrier

$208,978
Joanne N. Engel · University Of California, San Francisco · P01 · FY2012 · AI

Molecular Interactions of Toxin-Antitoxin Modules in P. aeruginosa (C. Bourne)

$208,971
Christina R Bourne · University Of Oklahoma · P20 · FY2018 · GM